Literature DB >> 8702839

Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units.

K Furukawa1, H Soejima, N Niikawa, H Shiku.   

Abstract

The beta1,4-N-acetylgalactosaminyltransferase (beta1,4GalNAc-T) (EC) gene is expressed in normal brain tissues and in various malignant transformed cells, such as malignant melanoma, neuroblastoma, and adult T cell leukemia. To analyze the regulatory mechanisms of gene expression, we determined the genomic organization of the beta1, 4GalNAc-T gene. The gene consists of at least 11 exons and spans >8 kilobase pairs. The coding region is located in exons 2-11. To determine the transcription initiation sites, 5'-rapid amplification of cDNA ends analysis and ribonuclease protection assays were performed using RNA obtained from the human melanoma cell line SK-MEL-31. Consequently, we defined three transcription initiation sites and the alternative usage of three exons. Exons 1a and 1b partially overlap; the latter is part (3'-side) of the former and corresponds to the 5'-noncoding region of the cDNA clone previously isolated. The third transcript, exon 1c, corresponds to nucleotides -520 to -412 (position +1 = A of ATG of beta1,4GalNAc-T cDNA), which are considered to be in intron 1 based on the cloned cDNA sequence. Ribonuclease protection assays revealed the corresponding protection bands in samples of the gene-expressing cell lines. 5'-Flanking regions of individual initiation sites showed promoter activity when analyzed by chloramphenicol acetyltransferase assay in SK-MEL-31 cells. The multiple transcription initiation sites and their promoters/enhancers identified here might be differentially involved in the cell type-specific expression of the beta1,4GalNAc-T gene. This gene was assigned to human chromosome 12q13.3 by means of fluorescence in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702839     DOI: 10.1074/jbc.271.34.20836

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

2.  Molecular cloning, gene organization and expression of the human UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sda/Cad antigen: evidence for an unusual extended cytoplasmic domain.

Authors:  Maria-Dolores Montiel; Marie-Ange Krzewinski-Recchi; Philippe Delannoy; Anne Harduin-Lepers
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 3.  The yeast expression system for recombinant glycosyltransferases.

Authors:  M Malissard; S Zeng; E G Berger
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

Review 4.  Anti-GD2 immunotherapy for neuroblastoma.

Authors:  Sameer Sait; Shakeel Modak
Journal:  Expert Rev Anticancer Ther       Date:  2017-08-14       Impact factor: 4.512

5.  Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.

Authors:  Avisek Banerjee; Barun Mahata; Arjun Dhir; Tapan Kumar Mandal; Kaushik Biswas
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

6.  GM2 ganglioside regulates the function of ciliary neurotrophic factor receptor in murine immortalized motor neuron-like cells (NSC-34).

Authors:  S Usuki; J Ren; I Utsunomiya; N R Cashman; J Inokuchi; T Miyatake
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

Review 7.  Functional roles of gangliosides in neurodevelopment: an overview of recent advances.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

8.  Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development.

Authors:  Yusuke Suzuki; Makoto Yanagisawa; Toshio Ariga; Robert K Yu
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

9.  Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.

Authors:  Julian Emanuel Alecu; Yuhsuke Ohmi; Robiul H Bhuiyan; Kei-Ichiro Inamori; Takahiro Nitta; Afshin Saffari; Hellen Jumo; Marvin Ziegler; Claudio Melo de Gusmao; Nutan Sharma; Shiho Ohno; Noriyoshi Manabe; Yoshiki Yamaguchi; Mariko Kambe; Keiko Furukawa; Mustafa Sahin; Jin-Ichi Inokuchi; Koichi Furakawa; Darius Ebrahimi-Fakhari
Journal:  Am J Med Genet A       Date:  2022-07-01       Impact factor: 2.578

Review 10.  Cloning and transcriptional regulation of genes responsible for synthesis of gangliosides.

Authors:  Guichao Zeng; Robert K Yu
Journal:  Curr Drug Targets       Date:  2008-04       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.